<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35281581</PMID><DateRevised><Year>2022</Year><Month>03</Month><Day>16</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2168-8184</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><Issue>3</Issue><PubDate><Year>2022</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>Secondary Adrenal Insufficiency After COVID-19 Diagnosed by Insulin Tolerance Test and Corticotropin-Releasing Hormone Test.</ArticleTitle><Pagination><StartPage>e23021</StartPage><MedlinePgn>e23021</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e23021</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.23021</ELocationID><Abstract><AbstractText>Coronavirus disease 2019 (COVID-19) can affect multiple organs and systems, including the endocrine system. Its symptoms can last for months, resulting in post-COVID-19 conditions, among others. A small number of patients have central adrenal insufficiency (CAI) months after recovery from COVID-19; nevertheless, its pathogenesis has not been fully elucidated. The insulin tolerance test (ITT) is a gold standard test assessing the hypothalamic-pituitary-adrenal axis, and the corticotropin-releasing hormone (CRH) test is useful for differentiating CAI into secondary (pituitary) and tertiary (hypothalamic) adrenal insufficiency. We present a case of new-onset CAI in a young female patient who had no medical history other than COVID-19. Adrenocorticotropin hormone and cortisol responded poorly to both insulin-induced hypoglycemia and CRH administration. These findings suggest that the pituitary gland may be the primary site of hypothalamic-pituitary-adrenal dysfunction, although magnetic resonance imaging of the pituitary gland was unremarkable. To our knowledge, this is possibly the first and only case report of new-onset secondary adrenal insufficiency after recovery from COVID-19 in which the ITT and the CRH test were performed and highly suggestive for the pathogenesis of not only post-COVID-19 CAI but also post-COVID-19 conditions.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022, Hamazaki et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hamazaki</LastName><ForeName>Kenya</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>General Internal Medicine, Kobe City Medical Center West Hospital, Kobe, JPN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nishigaki</LastName><ForeName>Tomoko</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Diabetes and Endocrinology, Kobe City Medical Center West Hospital, Kobe, JPN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuramoto</LastName><ForeName>Naoki</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Diabetes and Endocrinology, Kobe City Medical Center West Hospital, Kobe, JPN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oh</LastName><ForeName>Koji</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>General Internal Medicine, Kobe City Medical Center West Hospital, Kobe, JPN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Konishi</LastName><ForeName>Hiroki</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>General Internal Medicine, Kobe City Medical Center West Hospital, Kobe, JPN.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>03</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">adrenocorticotropic hormone deficiency</Keyword><Keyword MajorTopicYN="N">central adrenal insufficiency</Keyword><Keyword MajorTopicYN="N">coronavirus disease 2019</Keyword><Keyword MajorTopicYN="N">corticotropin-releasing hormone test</Keyword><Keyword MajorTopicYN="N">hypothalamic&#x2013;pituitary&#x2013;adrenal axis</Keyword><Keyword MajorTopicYN="N">insulin tolerance test</Keyword><Keyword MajorTopicYN="N">long covid</Keyword><Keyword MajorTopicYN="N">post-covid-19 conditions</Keyword><Keyword MajorTopicYN="N">secondary adrenal insufficiency</Keyword><Keyword MajorTopicYN="N">severe acute respiratory syndrome coronavirus 2</Keyword></KeywordList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>3</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>3</Month><Day>14</Day><Hour>5</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>3</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>15</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>3</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35281581</ArticleId><ArticleId IdType="pmc">PMC8908067</ArticleId><ArticleId IdType="doi">10.7759/cureus.23021</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues. Li MY, Li L, Zhang Y, Wang XS. Infect Dis Poverty. 2020;9:45.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7186534</ArticleId><ArticleId IdType="pubmed">32345362</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 and neurological impairment: hypothalamic circuits and beyond. Mussa BM, Srivastava A, Verberne AJ. Viruses. 2021;13:498.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8002703</ArticleId><ArticleId IdType="pubmed">33802995</ArticleId></ArticleIdList></Reference><Reference><Citation>Investigation of pituitary functions after acute coronavirus disease 2019 [In Press] Urhan E, Karaca Z, Unuvar GK, Gundogan K, Unluhizarci K. Endocr J. 2022</Citation><ArticleIdList><ArticleId IdType="pubmed">34987144</ArticleId></ArticleIdList></Reference><Reference><Citation>Assessment of the frequency and variety of persistent symptoms among patients with COVID-19: a systematic review. Nasserie T, Hittle M, Goodman SN. JAMA Netw Open. 2021;4:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8155823</ArticleId><ArticleId IdType="pubmed">34037731</ArticleId></ArticleIdList></Reference><Reference><Citation>Short-term and long-term rates of postacute sequelae of SARS-CoV-2 infection: a systematic review. Groff D, Sun A, Ssentongo AE, et al. JAMA Netw Open. 2021;4:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8515212</ArticleId><ArticleId IdType="pubmed">34643720</ArticleId></ArticleIdList></Reference><Reference><Citation>More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, Villapol S. Sci Rep. 2021;11:16144.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Clinical characteristics of Japanese patients who visited a COVID-19 aftercare clinic for post-acute sequelae of COVID-19/long COVID. Otsuka Y, Tokumasu K, Nakano Y, et al. Cureus. 2021;13:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8571943</ArticleId><ArticleId IdType="pubmed">34760415</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyazato Y, Tsuzuki S, Morioka S, et al. medRxiv. medRxiv: 2021. Risk factors associated with development and persistence of long COVID.</Citation></Reference><Reference><Citation>SARS-CoV-2 involvement in central nervous system tissue damage. Haidar MA, Shakkour Z, Reslan MA, et al. Neural Regen Res. 2022;17:1228&#x2013;1239.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8643043</ArticleId><ArticleId IdType="pubmed">34782556</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19, hypothalamo-pituitary-adrenal axis and clinical implications. Pal R. Endocrine. 2020;68:251&#x2013;252.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7186765</ArticleId><ArticleId IdType="pubmed">32346813</ArticleId></ArticleIdList></Reference><Reference><Citation>The impact of COVID-19 viral infection on the hypothalamic-pituitary-adrenal axis. Alzahrani AS, Mukhtar N, Aljomaiah A, et al. Endocr Pract. 2021;27:83&#x2013;89.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7837186</ArticleId><ArticleId IdType="pubmed">33554871</ArticleId></ArticleIdList></Reference><Reference><Citation>Central adrenal insufficiency and diabetes insipidus as potential endocrine manifestations of COVID-19 infection: a case report. Sheikh AB, Javaid MA, Sheikh AA, Shekhar R. Pan Afr Med J. 2021;38:222.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8140727</ArticleId><ArticleId IdType="pubmed">34046127</ArticleId></ArticleIdList></Reference><Reference><Citation>Diagnosis and treatment of primary adrenal insufficiency: an Endocrine Society Clinical Practice Guideline. Bornstein SR, Allolio B, Arlt W, et al. J Clin Endocrinol Metab. 2016;101:364&#x2013;389.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4880116</ArticleId><ArticleId IdType="pubmed">26760044</ArticleId></ArticleIdList></Reference><Reference><Citation>Pituitary insufficiency diagnosed after coronavirus disease-19: a case report [In Press] Kaya MG, Ert&#xfc;rk C, G&#xfc;ven M. Erciyes Med J. 2021</Citation></Reference><Reference><Citation>Long COVID: an overview. Raveendran AV, Jayadevan R, Sashidharan S. Diabetes Metab Syndr. 2021;15:869&#x2013;875.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8056514</ArticleId><ArticleId IdType="pubmed">33892403</ArticleId></ArticleIdList></Reference><Reference><Citation>Cortisol cut-points for the glucagon stimulation test in the evaluation of hypothalamic pituitary adrenal axis. Ach T, Yosra H, Jihen M, et al. Endocr J. 2018;65:935&#x2013;942.</Citation><ArticleIdList><ArticleId IdType="pubmed">29952338</ArticleId></ArticleIdList></Reference><Reference><Citation>Hypocortisolism in survivors of severe acute respiratory syndrome (SARS) Leow MK, Kwek DS, Ng AW, Ong KC, Kaw GJ, Lee LS. Clin Endocrinol (Oxf) 2005;63:197&#x2013;202.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7188349</ArticleId><ArticleId IdType="pubmed">16060914</ArticleId></ArticleIdList></Reference><Reference><Citation>Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Li W, Moore MJ, Vasilieva N, et al. Nature. 2003;426:450&#x2013;454.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7095016</ArticleId><ArticleId IdType="pubmed">14647384</ArticleId></ArticleIdList></Reference><Reference><Citation>Endocrine cells of the adenohypophysis in severe acute respiratory syndrome (SARS) Wei L, Sun S, Zhang J, et al. Biochem Cell Biol. 2010;88:723&#x2013;730.</Citation><ArticleIdList><ArticleId IdType="pubmed">20651845</ArticleId></ArticleIdList></Reference><Reference><Citation>Pathology and pathogenesis of severe acute respiratory syndrome. Gu J, Korteweg C. Am J Pathol. 2007;170:1136&#x2013;1147.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1829448</ArticleId><ArticleId IdType="pubmed">17392154</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>